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Abstract
Background: The long‐term health consequences of participation in American style
football (ASF) are not well understood.
Methods: We conducted a retrospective cohort study of men who had played in the NFL
after 1960. Participants were studied using a standardized self‐administered questionnaire
designed to determine both the exposure history to ASF and the prevalence of chronic
pain, sleep apnea, cardiometabolic disease, and neurocognitive impairment. Logistic
regression and negative binomial regression models were used to assess associations
between age, ethnicity, body‐mass index during professional football career, field position,
and football career duration with individual and multiple afflictions.
Results: In this cohort of former NFL players (n = 3745), approximately one quarter of the
eligible former players (27%) reported two or more medical afflictions (chronic pain,
cardiometabolic disease, sleep apnea, or neurocognitive impairment). Career duration was
significantly associated with an increase in the number of comorbidities. Age, race, and
body‐mass index were associated with all affliction categories, other than neurocognitive
impairment, which was similarly prevalent in middle‐aged players and older players. Earlier
age when first playing the sport was protective against cardiometabolic affliction.
Conclusions: Former NFL players report significant combinations of cross‐system
afflictions. Future work will be required to determine mechanistic underpinnings.
However, attention to the whole player, rather than specific organ systems seems
critical to improve long‐term health outcomes in former ASF professional athletes.
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1 | INTRODUCTION
The long‐term health implications of participation in American style
football (ASF) is under significant debate. Previous research has
described arthritis,1 cardiometabolic abnormalities,2 pain,3 sleep
apnea,4 and neurological issues.5 High profile cases of prominent
former ASF athletes and their health burdens are reported on
mainstream media outlets, which have furthered both the public and
scientific discourse. There is a prevalent notion that former ASF
players have poorer long‐term health outcomes despite the under-
standing that early participation in sport and exercise can predict
later‐life behaviors 6 and protect against certain medical afflictions.7
Body‐mass index (BMI), age, race and sex are all well‐established risk
factors for conditions such as cardiometabolic disease, sleep apnea and
dementia in the general population,8,9 and may represent predictive risk
factors in former ASF players. Furthermore, the unique demands of
participation in professional ASF may place players at greater risk for
certain medical conditions later in life, whereby football‐specific variables
such as position, career injuries, and age at first participation in the sport
have been associated with certain medical conditions.10-12
A large majority of previous research on the health of former ASF
players has been limited to the study of a single condition. Our previous
work has demonstrated that former NFL players report afflictions in
specific categories of medical conditions, including pain, sleep apnea,
cardiometabolic disease, and neurocognitive impairment.13 Emerging
evidence suggests that cross‐correlations between certain medical
conditions, such as sleep apnea and cardiovascular pathology (impaired
vascular and left ventricular diastolic function),14 may occur in ASF
players also. Thus, the study of individual medical conditions in isolation
may not capture the full extent to which ASF participation can affect
long‐term health and affliction in former players.
The aim of this study was two‐fold: to quantify multisystem
afflictions in former NFL players and to assess the impact of player
characteristics and career history on the presence of both single and
multisystem conditions. We hypothesized that former ASF players
would show afflictions in more than one biological system, and that
the characteristics of football exposure would be linked to single and
multisystem comorbidities in cardiometabolic disease, sleep apnea,
chronic pain, and neurocognitive impairment.
2 | METHODS
2.1 | Study design
The present study collected and analyzed questionnaire data from a
cohort of former National Football League (NFL) players. Ques-
tionnaires asked players to self‐report their demographics, exposure
to the game, and medical diagnoses. An attempt was made to contact
all living former players who participated in the American or National
Football League from 1960 to present. Before 1960, there were
substantial changes to the rules and equipment used by players.
Specifically, the transition to the helmet with a hard, plastic shell was
complete and well‐established by 1960, although changes to the
interior padding and facemask continue until the present day. Former
players were defined as any player that touched the NFL (training
camp, rookie camp, practice squad, or drafted by an NFL team), and
were no longer playing in the NFL. After testing that there was no
difference in response pattern to email or paper mailed question-
naires, we sent email or paper surveys to 13 200 former players with
either a home or email address that did not return as undeliverable.
Any duplicate responses (those who returned both a paper and
electronic survey) were removed. Of the 13 200 reachable players
(as of 2015), 3745 completed the survey (March 2017; ~28%
response rate). To estimate the representativeness of our sample in
regard to the wider former NFL player population (who did not
respond to our questionnaire) we calculated the difference in our
study variables from our sample compared to the nonresponders via
data available from Pro‐Football Reference (PFR), an online source for
historical data regarding NFL teams, players, scores and leaders.15 The
study was approved by an institutional review board.
2.2 | Player characteristics
We categorized age (reported in years) into groups of 34 or younger
(24‐34), 35 to 54, and 55 or older. Race was divided into three
categories; White, Black and other, where other includes American
Indian/Alaskan Native, Native Hawaiian/Pacific Islander, Asian,
Hispanic, and other. Professional body‐mass index (BMI) was
calculated (body weight [average annual during professional playing
time] in kilograms divided by height [current] in meters squared).
2.3 | Football exposure
Football exposures examined included position played, number of
seasons played in NFL, and age at which first began to play organized
ASF. Position played was categorized as linemen (offensive and
defensive) and nonlinemen (all other positions). Linemen were those
participants who had exclusively played this position during their
career. Position was categorized this way based on expected
differences in body habitus and composition, as well as hit
frequency/type. This categorization is consistent with the literature
suggesting linemen may be at higher risk of a number of medical
conditions.1,16 The number of professional seasons played was
reviewed for outliers, anyone reporting more than 15 years of
professional play (N = 100), not exclusive to the NFL, was verified
using PFR. Where there was a discrepancy of over or under three
professional years self‐reported from public records reviewed (PFR)
the item was set to missing (N = 40). The age at which players first
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began organized football was restricted to ages 4 to 25 to remove
outliers (N = 10).
2.4 | Affliction categories
Four affliction categories were created based on the medical
conditions highlighted via former player advisors and the medical
and scientific literature. These were: sleep apnea, chronic pain,
cardiometabolic disease, and neurocognitive impairment. These
affliction categories were assessed via self‐reported answers to the
questionnaire regarding medical diagnoses. As misconceptions about
health and disease are common,17 we attempted to avoid misclassi-
fication of medical conditions by asking a player if they had ever been
prescribed a medication for a given condition. For medical conditions
less likely to be susceptible to misconceptions, such as Alzheimer
disease, heart attack, or stroke, we asked “Has a health care provider
ever told you that you have any of the following diagnoses or health
outcomes?”. The affliction categories were defined as follows: Sleep
affliction was defined as having been diagnosed with sleep apnea.
Pain affliction was defined as reporting that pain medication for
chronic pain was prescribed by a medical provider and was still being
taken at the time of survey response. Cardiometabolic affliction was
defined as either being diagnosed with a heart attack or stroke by a
medical provider, or currently taking medication for at least two of
the following three medical conditions: diabetes, hypertension, and
high cholesterol. Neurocognitive affliction was defined as being
diagnosed by a medical provider with dementia or chronic traumatic
encephalopathy (CTE) or having ever been prescribed by a physician
medication for memory loss. Examination of multisystem comorbidity
was characterized by assessing those players who met the criteria for
one, two, three, or all four affliction categories.
2.5 | Statistical analysis
Analysis of individual affliction types were compared using logistic
regression to assess the independent associations of player character-
istics and football exposure, adjusting for all covariates, with affliction
(afflicted or not afflicted). Results are reported as odds ratios where
significance of P<0.05 is measured by a confidence interval that does not
include one. Due to overdispersion in the affliction count, a negative
binomial regression model was used to assess the relationship of player
characteristics and the number of simultaneous afflictions. Regression
coefficients represent the log of the expected count of the dependent
variable for each one‐unit change in the predictor variables. We present
the exponentiated coefficients (called mean ratio [MR]), which indicates
the fold change in the count as the exposure variable increases by one
unit. We used χ2 statistics and t tests to test the difference in study
variables between our responders and nonresponders (from PFR) as an
estimate of sample representativeness. For this representativeness
estimation, age from PFR (where only date of birth is provided) was
calculated by assuming that the nonresponders filled out the ques-
tionnaire on the last date a responder did. Statistical analyses were
performed in Stata, version 14 (Statacorp LLC, TX).
3 | RESULTS
3.1 | Player demographics
At the time of analysis, a total of 3745 former players had responded to
our questionnaire. Most respondents were White (59%), with Black
players representing 37% and “other” representing 4% of the total
cohort. Linemen (offensive and defensive) represented 30% of
respondents. The mean age ± standard deviation of the respondents
was 52 ± 14 years. Average weight during professional play was
239 ± 42 lbs; the mean BMI during professional play was 30 ± 4.
Respondents played an average of 7 ± 4 years professionally and were
12 ± 3‐years of age when they first played organized football (Table 1).
3.2 | Individual affliction associations
A quantification of individual medical conditions reported by our cohort
of former players is reported elsewhere.13 Age was significantly
associated with greater odds of sleep apnea, chronic pain, and
cardiometabolic affliction, in which older players (55 years and above)
were significantly more likely to be afflicted in these categories compared
to younger players (Table 2). Players over 35 years of age, however, had
similar odds of neurocognitive affliction compared to younger players.
Race and BMI were also predictive of afflictions in all categories (Table 2).
Black players were approximately one and a half times more likely to
report afflictions in all categories compared to White players, and those
TABLE 1 Player sample characteristics
Age (y), n/N (%)
34 or younger 465/3743 (12)
35‐54 1528/3743 (41)













Professional BMI, mean (SD), kg/m2 30.4 (4.2)
Number of seasons played, mean (SD) 6.7 (3.8)
Age when started football, mean (SD), y 11.8 (3.1)
aSubjects had the option to select more than one category.
bOther includes American Indian/Alaskan Native, Native Hawaiian/Pacific
Islander, Asian, Hispanic, other, and multirace.
cOnly played the offensive or defensive line. Special teams were classified
as nonlinemen.
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who listed “other” for ethnicity were almost twice as likely to report sleep
apnea compared to White players. Number of seasons played was
essentially unrelated to any of the afflictions. However, older the age
when participation in organized ASF first began increased the odds of
cardiometabolic affliction significantly but marginally by 4% (Table 2).
3.3 | Multisystem afflictions
Approximately 27% of players were categorized as having more
than one affliction and 9% had more than two, (Figure 1A). Figure
1B illustrates the combinations of afflictions reported by those










34 & under Referent group Referent group Referent group Referent group
35‐54 2.99 (2.09‐4.27) 1.76 (1.32‐2.36) 3.33 (2.20‐5.06) 2.16 (1.50‐3.11)
55 and above 5.64 (3.91‐8.15) 3.44 (2.56‐4.63) 13.03 (8.57‐19.82) 2.75 (1.89‐3.99)
Ethnicitya
White Referent group Referent group Referent group Referent group
Black 1.56 (1.30‐1.86) 1.67 (1.42‐1.97) 1.57 (1.32‐1.86) 1.70 (1.41‐2.05)
Otherb 1.94 (1.33‐2.83) 0.87 (0.59‐1.30) 0.87 (0.57‐1.33) 1.20 (0.77‐1.86)
Position
Nonlinemen Referent group Referent group Referent group Referent group
Linemen 1.10 (0.88‐1.39) 1.05 (0.85‐1.30) 0.88 (0.70‐1.10) 0.99 (0.77‐1.28)
Professional BMI (5‐unit increase), kg/m2 1.67 (1.46‐1.92) 1.26 (1.11‐1.42) 1.38 (1.21‐1.58) 1.05 (0.91‐1.21)
Per professional season played 1.00 (0.98‐1.03) 1.02 (0.99‐1.04) 0.99 (0.96‐1.01) 1.01 (0.99‐1.04)
Per year of age when started football 1.01 (0.99‐1.04) 0.99 (0.96‐1.01) 1.04 (1.01‐1.07) 1.02 (0.99‐1.05)
Abbreviations: BMI, body‐mass index; CI, confidence interval; OR, odds ratio.
aSubjects had the option to select more than one category.
bOther includes American Indian/Alaskan Native, Native Hawaiian/Pacific Islander, Asian, Hispanic and other.
cAdjusted (for all other covariates) odds ratio; 95% CIs are significant in those which do not include 1.0.
F IGURE 1 Prevalence of multiple afflictions within the cohort of former ASF players. A greater numerical proportion of players reported at
least one affliction than none (A). The combinations of multisystem afflictions for those who report two and three afflictions, respectively, are
shown in (B). The most common coupling of multisystem afflictions were pain, cardiometabolic (CM), and sleep apnea. ASF, American style
football; NFL, National Football League [Color figure can be viewed at wileyonlinelibrary.com]
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with two and three afflictions, respectively. Cardiometabolic and
pain afflictions were the most common comorbid afflictions for
those with two types of afflictions (23%), whereas for those
reporting three afflictions, cardiometabolic, pain, and sleep apnea
(36%) were the most common.
The MR of multisystem afflictions was significantly higher in middle‐
aged players and older players compared to players aged 34 or younger
after adjusting all other variables in the model (Table 3). That is, players
aged over 54 years were found to have a mean fold increase in the
number of multisystem afflictions roughly three times greater than those
aged 34 and under. Black players were also significantly more likely to
have more afflictions compared toWhite players. Linemen did not have a
greater fold increase in multiple afflictions compared to nonlinemen, but
for every 5‐unit increase in professional BMI, a 19% increase in
multisystem afflictions was found. In contrast to the individual afflictions
not being associated with the number of professional seasons played,
having multiple afflictions was significantly associated with professional
seasons played. While an older age at which players began to play
organized football was associated with more afflictions, this did not reach
statistical significance at the 0.05 level.
4 | DISCUSSION
More than half of the former NFL players in our cohort reported having
at least one affliction, either sleep apnea, chronic pain, cardiometabolic
disease, or neurocognitive impairment. Age was a significant predictor
of all afflictions apart from neurocognitive afflictions. Middle‐aged
former players were just as likely to report neurocognitive impairment
as older players, a finding which contributes to the growing under-
standing of an association between ASF participation and neurocogni-
tive impairment that is above and beyond that which can be explained
by aging alone. Multisystem afflictions were prevalent among our
cohort with just over a quarter of former players reporting two or more
afflictions. This prevalence of multisystem afflictions is higher than the
one reported in the general population (21%).18,19 Career duration was
marginally predictive of multiple afflictions, whereas earlier age when
first starting organized ASF appeared to be protective against
cardiovascular affliction.
Previous research on the health of former and current ASF
players has mostly been limited to the study of single system
afflictions.1,2,4,20 While our previous work13 confirmed the presence
of chronic health conditions (pain, cardiometabolic disease, sleep
apnea, and neurocognitive impairment) previously described in the
literature,1-5 the results of this paper are novel and notable. We
found that more than one‐quarter of former players reported
afflictions in multiple cross‐system morbidities. Multisystem afflic-
tions are key contributors to overall morbidity, long‐term disability,
poorer functional quality of life, treatment complications, and
mortality.18 Emerging evidence suggests that coupling of cross‐
system comorbidities within ASF players may be particularly
prevalent from a rather early age.14 Our results reveal the most
common coupling of multisystem afflictions between cardiometa-
bolic, sleep apnea, and pain. This is consistent with a recent study of
collegiate ASF athletes that found impairments in measures of
arterial stiffness and left ventricular diastolic function in those with
sleep disordered breathing (defined as ≥5 on the apnea‐hypopnea
index), compared to those without sleep disordered breathing.14 The
understanding that cross‐system comorbidities are present in former
ASF players emphasizes the importance of targeted screening for
multiple afflictions as well as the importance of future work to
identify linking pathobiological processes.
The etiology of the development of multisystem comorbidity in
former ASF players is unknown and the physiological correlates are
likely to be complex, an understanding of which may lead to novel
risk factors for postretirement diseases. In the general population
age, race, and body habitus are common risk factors for individual
afflictions 8,21-23 and our results suggest these are similar in former
players. ASF participation is associated with atypical player pheno-
types unique to the game that may also contribute to the
development of multisystem afflictions. High training‐associated
static hemodynamic stress and low aerobic conditioning (especially
in linemen) is common,24 as is deliberate body‐mass gain13 and high‐
calorie diets,25 routine use of nonsteroidal anti‐inflammatory
drugs,26 and the use and misuse of opioids.3 Repetitive blunt trauma
to both the body and head is also an inherent aspect of participation
in ASF caused by player‐player impacts and the culminative effect of
more years of this type of exposure appears to increase the number
of later‐life multisystem afflictions.





34 and under Referent group
35‐54 2.03 (1.73‐2.39) <.001
55 and above 3.38 (2.88‐3.97) <.001
Raceb
White Referent group
Black 1.36 (1.27‐1.47) <.001
Otherc 1.10 (0.92‐1.31) .67
Position
Nonlinemen Referent group
Linemen 1.03 (0.94‐1.13) .49
Professional BMI (5‐unit increase),
kg/m2
1.19 (1.13‐1.25) <.001
Per season played 1.01 (1.00‐1.02) .01
Per year of age when started football 1.01 (1.00‐1.02) .06
Abbreviations: BMI, body‐mass index; CI, confidence interval.
a3 = 3+ due to small cell issues in the four categories.
bSubjects had the option to select more than one category.
cOther includes American Indian/Alaskan Native, Native Hawaiian/Pacific
Islander, Asian, Hispanic and other.
dAdjusted mean ratio; 95% CIs.
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Whereas older age predicted cardiometabolic, pain and sleep apnea
afflictions, it was not predictive of neurocognitive impairment. Younger
(35‐54years) and older (≥55 years) players had similar odds of reporting
this affliction. An assumed link between football exposure and cognitive
impairment in the public eye may cause bias regarding memory loss
medication usage among former players (for which ~70% met the
fulfillment criteria for this affliction category) and a potential selection
bias in our study (those players who are more impaired/more
concerned) may have increased the prevalence rate of this affliction
category. Nevertheless, given that the age‐standardized prevalence of
all cause dementia in over 60‐year‐olds is between 5% and 7%,27 the
proportion of players who reported neurocognitive affliction in our
cohort (17%; see Churchil et al13) is significantly large enough to still be
a concern even if neurocognitive affliction is absent in all of the eligible
former players not recruited into this study. Neurocognitive impairment
associated with repetitive head trauma 5 and a trend towards early
onset of Alzheimer’s disease compared to the US general population11
have previously been reported in former NFL players. While long-
itudinal studies are required to fully establish the incidence rate of
dementia diagnosis, our results further corroborate the associations
between ASF participation and neurocognitive issues, especially among
younger former players. In this context, the finding of high prevalence of
multisystem comorbidities is potentially particularly relevant since, for
example, sleep apnea can accelerate the progression of dementia.28
Previous research has suggested that prognostic implications of
certain risk factors for cardiometabolic disease in the general
population, such as obesity,29 hypertension,30 and arterial stiffness31
are comparable in ASF players.2,4 Certain protective factors for
cardiometabolic afflictions however, such as adherence to sport and
exercise, are likely to be present in athletes, and especially present in
those who begin playing ASF earlier. Early‐life patterns can predict
later‐life behaviors, such as physical exercise,6 which is associated
with a 20% to 30% reduction in cardiovascular disease.7 Our results
suggest that those players who avoided early‐life comorbidities and
who began ASF participation earlier were less likely to develop
cardiometabolic afflictions in later life. Consequently, while certain
factors associated with the game are related to other comorbidities,
early participation in ASF may promote certain lifestyle factors, or be
related to certain body habitus (larger players who may have been
drafted into the game later, purely based on body size), which are
ultimately protective against the development of cardiometabolic
afflictions.
The findings here should be interpreted in light of their
limitations. While we attempted to minimize misclassification of
medical conditions with our survey questions, accuracy of reporting
health conditions is subject to the limitations of self‐reported data.
Nonetheless, accuracy in the reporting of certain health conditions
through this type of survey study design has been reported in other
populations.32 The selection bias regarding the type of former player
who enrolls in the study is also a limitation. It is not possible to know
whether players more or less afflicted in the medical conditions
studied were more or less likely to enroll. We had a response rate of
~28%. When we compared our participants to the contacted
nonparticipants using data publicly available on ProReference Football,
we found the mean age was likely to be representative of the overall
population (53.3 ± 14.1 for responders compared to 51 ± 12.1 for
nonresponders). Although significant differences in weight
(232.8 ± 38.3 pounds for responders, 229.8 ± 39.9 pounds for
nonresponders), years played (6 ± 3.6 for responders, 5.2 ± 3.5 for
nonresponders), and the proportion of linemen compared to nonline-
men (28.5% linemen in the responders group, 20.8% linemen in the
nonresponders group) existed. As such, because of these differences
we must view the quantification of overall prevalence of the medical
conditions among our sample of former NFL players with caution. We
believe that the exposure‐outcome relationships are less likely to
have been affected based on selection bias as this would require
former players to be more or less likely to enter the study based on
both their affliction status and a certain demographic or football
exposure status. Longitudinal follow‐up studies and biological
mechanistic insights are necessary to unveil the true extent of these
afflictions in former NFL players and to develop strategies to
mitigate the burden of affliction.
In summary, we show that former NFL players report both
individual as well as comorbid afflictions across multiple domains. We
found that while some factors inherent in those players who start the
game earlier seem protective against cardiometabolic afflictions,
other factors present a clear risk to early neurocognitive issues. Most
relevant for long‐term wellbeing, we found a high prevalence of
multisystem afflictions. Quantification of intricate, multisystem
afflictions and the understanding of cross‐system correlates of
comorbidity in former ASF players ought to lead to enhanced
targeted screening and treatment.
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